Estimating the cost of cancer care in British Columbia and Ontario: A Canadian inter-provincial comparison

Claire De Oliveira, Reka Pataky, Karen E. Bremner, Jagadish Rangrej, Kelvin K.W. Chan, Winson Y. Cheung, Jeffrey S Hoch, Stuart Peacock, Murray D. Krahn

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Costing studies are useful to measure the economic burden of cancer. Comparing costs between healthcare systems can inform evaluation, development or modification of cancer care policies. Objectives: To estimate and compare cancer costs in British Columbia and Ontario from the payers' perspectives. Methods: Using linked cancer registry and administrative data, and standardized costing methodology and analyses, we estimated costs for 21 cancer sites by phase of care to determine potential differences between provinces. Results: Overall, costs were higher in Ontario. Costs were highest in the initial post-diagnosis and pre-death phases and lowest in the pre-diagnosis and continuing phases, and generally higher for brain cancer and multiple myeloma, and lower for melanoma. Hospitalization was the major cost category. Costs for physician services and diagnostic tests differed the most between provinces. Conclusions: The standardization of data and costing methodology is challenging, but it enables interprovincial and international comparative costing analyses.

Original languageEnglish (US)
Pages (from-to)95-108
Number of pages14
JournalHealthcare Policy
Volume12
Issue number3
StatePublished - 2017

Fingerprint

British Columbia
Ontario
Costs and Cost Analysis
Neoplasms
Multiple Myeloma
Routine Diagnostic Tests
Brain Neoplasms
Registries
Melanoma
Hospitalization
Economics
Delivery of Health Care
Physicians

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

De Oliveira, C., Pataky, R., Bremner, K. E., Rangrej, J., Chan, K. K. W., Cheung, W. Y., ... Krahn, M. D. (2017). Estimating the cost of cancer care in British Columbia and Ontario: A Canadian inter-provincial comparison. Healthcare Policy, 12(3), 95-108.

Estimating the cost of cancer care in British Columbia and Ontario : A Canadian inter-provincial comparison. / De Oliveira, Claire; Pataky, Reka; Bremner, Karen E.; Rangrej, Jagadish; Chan, Kelvin K.W.; Cheung, Winson Y.; Hoch, Jeffrey S; Peacock, Stuart; Krahn, Murray D.

In: Healthcare Policy, Vol. 12, No. 3, 2017, p. 95-108.

Research output: Contribution to journalArticle

De Oliveira, C, Pataky, R, Bremner, KE, Rangrej, J, Chan, KKW, Cheung, WY, Hoch, JS, Peacock, S & Krahn, MD 2017, 'Estimating the cost of cancer care in British Columbia and Ontario: A Canadian inter-provincial comparison', Healthcare Policy, vol. 12, no. 3, pp. 95-108.
De Oliveira C, Pataky R, Bremner KE, Rangrej J, Chan KKW, Cheung WY et al. Estimating the cost of cancer care in British Columbia and Ontario: A Canadian inter-provincial comparison. Healthcare Policy. 2017;12(3):95-108.
De Oliveira, Claire ; Pataky, Reka ; Bremner, Karen E. ; Rangrej, Jagadish ; Chan, Kelvin K.W. ; Cheung, Winson Y. ; Hoch, Jeffrey S ; Peacock, Stuart ; Krahn, Murray D. / Estimating the cost of cancer care in British Columbia and Ontario : A Canadian inter-provincial comparison. In: Healthcare Policy. 2017 ; Vol. 12, No. 3. pp. 95-108.
@article{c8b23884d39c428a8062b55fcd55fa81,
title = "Estimating the cost of cancer care in British Columbia and Ontario: A Canadian inter-provincial comparison",
abstract = "Background: Costing studies are useful to measure the economic burden of cancer. Comparing costs between healthcare systems can inform evaluation, development or modification of cancer care policies. Objectives: To estimate and compare cancer costs in British Columbia and Ontario from the payers' perspectives. Methods: Using linked cancer registry and administrative data, and standardized costing methodology and analyses, we estimated costs for 21 cancer sites by phase of care to determine potential differences between provinces. Results: Overall, costs were higher in Ontario. Costs were highest in the initial post-diagnosis and pre-death phases and lowest in the pre-diagnosis and continuing phases, and generally higher for brain cancer and multiple myeloma, and lower for melanoma. Hospitalization was the major cost category. Costs for physician services and diagnostic tests differed the most between provinces. Conclusions: The standardization of data and costing methodology is challenging, but it enables interprovincial and international comparative costing analyses.",
author = "{De Oliveira}, Claire and Reka Pataky and Bremner, {Karen E.} and Jagadish Rangrej and Chan, {Kelvin K.W.} and Cheung, {Winson Y.} and Hoch, {Jeffrey S} and Stuart Peacock and Krahn, {Murray D.}",
year = "2017",
language = "English (US)",
volume = "12",
pages = "95--108",
journal = "Healthcare Policy",
issn = "1715-6572",
publisher = "Longwoods Publishing Corp.",
number = "3",

}

TY - JOUR

T1 - Estimating the cost of cancer care in British Columbia and Ontario

T2 - A Canadian inter-provincial comparison

AU - De Oliveira, Claire

AU - Pataky, Reka

AU - Bremner, Karen E.

AU - Rangrej, Jagadish

AU - Chan, Kelvin K.W.

AU - Cheung, Winson Y.

AU - Hoch, Jeffrey S

AU - Peacock, Stuart

AU - Krahn, Murray D.

PY - 2017

Y1 - 2017

N2 - Background: Costing studies are useful to measure the economic burden of cancer. Comparing costs between healthcare systems can inform evaluation, development or modification of cancer care policies. Objectives: To estimate and compare cancer costs in British Columbia and Ontario from the payers' perspectives. Methods: Using linked cancer registry and administrative data, and standardized costing methodology and analyses, we estimated costs for 21 cancer sites by phase of care to determine potential differences between provinces. Results: Overall, costs were higher in Ontario. Costs were highest in the initial post-diagnosis and pre-death phases and lowest in the pre-diagnosis and continuing phases, and generally higher for brain cancer and multiple myeloma, and lower for melanoma. Hospitalization was the major cost category. Costs for physician services and diagnostic tests differed the most between provinces. Conclusions: The standardization of data and costing methodology is challenging, but it enables interprovincial and international comparative costing analyses.

AB - Background: Costing studies are useful to measure the economic burden of cancer. Comparing costs between healthcare systems can inform evaluation, development or modification of cancer care policies. Objectives: To estimate and compare cancer costs in British Columbia and Ontario from the payers' perspectives. Methods: Using linked cancer registry and administrative data, and standardized costing methodology and analyses, we estimated costs for 21 cancer sites by phase of care to determine potential differences between provinces. Results: Overall, costs were higher in Ontario. Costs were highest in the initial post-diagnosis and pre-death phases and lowest in the pre-diagnosis and continuing phases, and generally higher for brain cancer and multiple myeloma, and lower for melanoma. Hospitalization was the major cost category. Costs for physician services and diagnostic tests differed the most between provinces. Conclusions: The standardization of data and costing methodology is challenging, but it enables interprovincial and international comparative costing analyses.

UR - http://www.scopus.com/inward/record.url?scp=85016773523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016773523&partnerID=8YFLogxK

M3 - Article

C2 - 28277207

AN - SCOPUS:85016773523

VL - 12

SP - 95

EP - 108

JO - Healthcare Policy

JF - Healthcare Policy

SN - 1715-6572

IS - 3

ER -